Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Dunedin Enterprise exits Practice Plan

14 Aug 2013 09:31

RNS Number : 6699L
Dunedin Enterprise Inv Trust PLC
14 August 2013
 

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") has exited from its investment in Practice Plan, a leading UK provider of membership plans and other support services to dental practices. The sale to Wesleyan Assurance Society is subject to regulatory approval at which point the transaction will complete. On completion the investment in Practice Plan will have achieved a realised multiple on equity of 2.7x the amount invested by the Trust. This represents the third portfolio exit for Dunedin Enterprise this year, following the sale of its investment in FSN Capital in May 2013 and in Egeria in February 2013.

Capital and accrued interest in Practice Plan were valued at £12.6m as at 31 March 2013, the last published valuation. Total proceeds from the investment on completion will amount to £14.8m, consisting of capital of £8.9m and income of £5.9m.

 

The cost of the investment at 31 March 2013 was £5.6m. The capital gain on realisation of the investment amounts to £3.3m, at least 50% of which (£1.6m) will be returned to shareholders in due course.

 

Dunedin, the manager of Dunedin Enterprise, backed the MBO of Practice Plan in September 2005. In October 2011 Practice Plan acquired Isoplan, a UK dental plan provider, and Medenta, the market leader in dental patient finance.

 

Shaun Middleton, Managing Partner of Dunedin, said: "The investment in Practice Plan has produced a strong return for Dunedin Enterprise shareholders. The business, with Dunedin's backing, has performed very well, successfully integrating two acquisitions and embarking on an internationalisation strategy. "

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDIIDBBGXS
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.